Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20210113050028N2
IRCT20210113050028N2
Recruiting
Phase 3

Comparison of the effect of vaginal misoprostol alone and in combination with Evening primrose Capsule on the state of delivery in pregnant women candidate for pregnancy termination

Ardabil University of Medical Sciences0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsormal Vaginal Delivery.

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
ormal Vaginal Delivery.
Sponsor
Ardabil University of Medical Sciences
Enrollment
30
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Single pregnancy
  • •Fetal weight less than 4 kg
  • •Amniotic fluid index more than 5 cm
  • •normal fetus NST
  • •Bishop score less than 7
  • •Absence of labor pains in the mother

Exclusion Criteria

  • •Rupture of membranes
  • •Possibility of fetal abnormalities
  • •need for urgent delivery
  • •Hypersensitivity to prostaglandins and evening primrose
  • •History of seizures
  • •history of schizophrenia with phenothiazin Prescription
  • •Bleeding disorders or taking anticoagulants
  • •Fallen in FHR
  • •Malpresentation
  • •Fetal disorders such as hydrocephalia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
The Effect of Laminaria with Vaginal Misoprostol on Cervical Preparation in Induction of Second Trimester Abortio
IRCT20190529043759N1Zahedan University of Medical Sciences90
Not yet recruiting
Not Applicable
Comparison of the effect of vaginal misoprostol and evening primrose oil capsules with misoprostol alone on the consequences of abortion in women with intrauterine fetal deaththe consequences of abortion in women with intrauterine fetal death.Medical abortion : complete or unspecified, without complicationO04.9
IRCT20181207041873N3Iran University of Medical Sciences84
Completed
Phase 2
Comparison the effect of vaginal Misoprostol and vaginal Isoniazid for cervical ripening prior to hysteroscopy proceduresAbnormal uterine and vaginal bleeding, unspecified.Abnormal uterine and vaginal bleeding, unspecified
IRCT2015112821506N4Iran University of Medical Sciences100
Completed
Phase 2
Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management pregnancy terminations with IUFD
IRCT20181218042033N2Bandare-abbas University of Medical Sciences106
Not yet recruiting
Not Applicable
Comparing a vaginal tablet (Misoprostol) and device (Dilapan) kept inside the cervix for dilatation of cervix before operative hysterosocpic proceduresHealth Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified
CTRI/2020/04/024844Jawaharlal Institute of Postgraduate Medical Education and Research